Tumor Molecular Profiling in Early Phase Clinical Trials
NCT04510766 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2025-11-18
Summary
Prospective, single centre, non-interventional exploratory research project that will be conducted on biological material and health-related personal data collected.
Conditions
- Advanced Solid Tumor
- Lymphoma
Sponsors & Collaborators
-
Ente Ospedaliero Cantonale, Bellinzona
collaborator OTHER -
Istituto Cantonale di Patologia
collaborator OTHER -
Oncology Institute of Southern Switzerland
lead OTHER
Principal Investigators
-
Ilaria Colombo, MD · Oncology Institute of Southern Switzerlan
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-10-01
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
NCT02622581 ·Status: RECRUITING
-
Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer
NCT00213733 ·Status: COMPLETED
-
Characterization of Methylation Patterns in Lung Cancer
NCT02373917 ·Status: COMPLETED
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN
-
Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.
NCT06016569 ·Status: RECRUITING ·Phase: NA
-
Multidisciplinary Integrated Platform for a Technological Innvovative Approach to Oncotherapies
NCT05818020 ·Status: COMPLETED
-
Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian Cohor
NCT06076005 ·Status: RECRUITING
-
Proteomics in Small Cell Lung Cancer
NCT05623956 ·Status: RECRUITING
-
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT01580982 ·Status: RECRUITING
-
Metabolomics Predict Therapy Response
NCT03736993 ·Status: COMPLETED ·Phase: NA
-
Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer
NCT04187768 ·Status: COMPLETED
-
Role of Intrapulmonary Lymph Nodes in Patients With NSCLC and Visceral Pleural Invasion
NCT05596578 ·Status: RECRUITING
-
Molecular Profiling Project
NCT04025515 ·Status: SUSPENDED
-
LC-NMR Study Biomarkers to Detect Lung Cancer
NCT02024113 ·Status: COMPLETED
-
Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New Biomarkers
NCT03658460 ·Status: COMPLETED
-
Enumeration of Circulating Tumour Cells (CTCs) in Patients With Advanced Solid Malignancy Using Complementary Metal Oxide Semiconductor (CMOS) Technology
NCT01596452 ·Status: UNKNOWN
-
OncoSNIPE - Study of Molecular Profiles Associated With the Development of Resistance in Solid Cancer Patients
NCT04548960 ·Status: UNKNOWN ·Phase: NA
-
Personalizing Adoptive Cell Transfer for Solid Tumors: Towards a New Patient-tailored Treatment Option
NCT06922266 ·Status: NOT_YET_RECRUITING
-
Transcriptomal and Molecular Characterization of Tumor Associated Monocytes/Macrophages in Human Cancers
NCT00979277 ·Status: UNKNOWN
-
Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.
NCT03220230 ·Status: COMPLETED
-
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
NCT03633006 ·Status: COMPLETED
-
Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
NCT07325864 ·Status: RECRUITING
-
Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer
NCT00042926 ·Status: COMPLETED ·Phase: NA
-
Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients
NCT05619562 ·Status: COMPLETED
-
NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"
NCT03771404 ·Status: UNKNOWN ·Phase: NA